Home >> Marketplace Archives >> Thermo Fisher acquires IntegenX, 5/18

Thermo Fisher acquires IntegenX, 5/18

Print Friendly, PDF & Email


May 2018—Thermo Fisher Scientific has acquired IntegenX, a forensic DNA testing firm. IntegenX products include the RapidHIT platforms, software analysis tools, and related consumables that are compatible with Thermo Fisher’s short tandem repeat chemistries for human identification. IntegenX technology is used in government laboratories to generate forensic DNA profiles from samples in 90 minutes.

Thermo Fisher Scientific, 866-356-0354


Check Also

CMS extends coverage of Oncomine Dx test, 5/18

May 2018—Thermo Fisher Scientific announced its Oncomine Dx Target Test has been approved for coverage by the Centers for Medicare and Medicaid Services as part of the agency’s national coverage determination for next-generation sequencing in vitro diagnostic tests.